|
2024
|
Invention
|
Short acting esters of ivabradine.
Some aspects provide novel ivabradine-like compounds and phar... |
|
2023
|
Invention
|
Ultra short acting anti-arrhythmic agents. Some aspects provide novel dofetilide derivatives and ... |
|
2020
|
Invention
|
Ultra short acting anti-arrhythmic agents. The present invention provides novel sotalol derivativ... |
|
2018
|
Invention
|
Metolazone emulsion formulation. The present invention relates to pharmaceutical formulations com... |
|
2012
|
Invention
|
Parenteral dextrose formulation of clopidogrel. 50W, which is useful in the prevention of platele... |
|
|
Invention
|
Thrombosis warning system.
The present invention relates to a device for detecting the potential... |
|
|
Invention
|
Methadone chiral isolate as an improved pharmaceutical.
The present invention relates to a metho... |
|
2010
|
Invention
|
Parenteral formulation of clopidogrel. Described herein are ways to solubilize clopidogrel for pa... |
|
2009
|
Invention
|
Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administratio... |
|
2007
|
Invention
|
Parenteral solution containing amiodarone in nndma (n,n,-dimethylacetamide). Disclosed herein are... |
|
2005
|
Invention
|
Synthesis and separation of optically active isomers of erythromycin and their biological actions... |
|
2002
|
Invention
|
Optically active isomers of quinine and quinidine and their respective biological action. The pre... |
|
1995
|
Invention
|
Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides.
|
|
1994
|
Invention
|
Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides. Disc... |
